{"abdominal pain": 2.51, "acute kidney injury": 2.42, "alopecia": 3.12, "anaemia": 2.54, "ascites": 7.13, "carcinoid crisis": 976.11, "disease progression": 11.58, "flushing": 9.37, "general physical health deterioration": 9.9, "haematotoxicity": 33.18, "haemoglobin decreased": 2.15, "hepatic failure": 4.64, "hepatic function abnormal": 2.11, "ill-defined disorder": 145.33, "illness": 3.5, "inappropriate schedule of product administration": 3.29, "intentional product use issue": 7.53, "intestinal obstruction": 13.82, "jaundice": 4.36, "laboratory test abnormal": 14.49, "leukopenia": 7.89, "lymphopenia": 29.69, "malignant neoplasm progression": 9.0, "metastases to liver": 15.22, "myelodysplastic syndrome": 18.62, "neoplasm progression": 3.79, "neuroendocrine tumour": 435.77, "neutropenia": 3.85, "pancreatic neuroendocrine tumour": 134.58, "pancytopenia": 5.32, "platelet count decreased": 5.84, "product use in unapproved indication": 2.15, "renal impairment": 3.49, "thrombocytopenia": 18.22}